Cell-Easy
Toulouse, FR
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
76.8
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
✓ EMA GMP (2)
○ MHRA GMP
Quick Facts: Cell-Easy
- Signal Score
- 76.8/100 (as of 2026-04-29)
- Quality Compliance
- 100.0/100 — No FDA inspection records found for this manufacturer
- Headquarters
- Toulouse, FR
- Modalities
- Cell Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Cell-Easy
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates2 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
53.0
1 manufacturing site: Toulouse, FR
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Sites: Toulouse, FR
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press1 articles
1 manufacturing site: Toulouse, FR
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Cell-Easy EMA GMP Compliance 2 certificates
2024-02
2022-02
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| 2024_HPF_FR_090 | Cell-Easy | France | 2024-02-01 | COMPLIANT |
| 2022_HPF_FR_065 | Cell-Easy | France | 2022-02-18 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Jul 04, 2026
Recent News 1 articles
Cell-Easy Launches an iPSC-Derived Beta Cell Program to Tackle Scale-Up Challenges - BioInformant
Cell-Easy Launches an iPSC-Derived Beta Cell Program to Tackle Scale-Up Challenges BioInformant
Frequently Asked Questions About Cell-Easy
Does Cell-Easy hold EMA or MHRA GMP certificates?
CDMO Signal tracks 2 EMA GMP certificates for Cell-Easy.
What is Cell-Easy's CDMO Signal Score?
Cell-Easy has a Signal Score of 77/100, based on quality, operations, financial stability, and capacity data.
Evaluating Cell-Easy for a manufacturing program?
Use the free AI matchmaker to compare Cell-Easy against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
CELLforCURE (SEQENS)
Les Ulis, FR
Signal Score: 80.3
CAR-T, Cell Therapy
Excellos
La Rochelle, FR
Signal Score: 59.0
Cell Therapy, CAR-T
SK pharmteco
Corbeil-Essonnes, FR · King of Prussia, PA
Cell Therapy, AAV, Lentiviral, Plasmid DNA
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 90.8
CAR-T, Cell Therapy